Authors
Wenyu Liu, Jennifer Collister, Thomas Littlejohns, Iain James Turnbull, Robert Clarke, David John Hunter
Published in
BMJ public health. Volume 4. Issue 3. Pages e004815. Epub Sep 23, 2026.
Abstract
To assess the prevalence, detection, treatment and control of hypertension in England.
Cross-sectional analysis of baseline blood pressure measurements from the Our Future Health study.
Over 200 enrolment centres across England, 2022-2025.
1.4 million adults aged ≥18 years with available clinic blood pressure measurements.
Hypertension was defined according to WHO guidelines as systolic blood pressure (SBP) ≥140 mm Hg, diastolic blood pressure (DBP) ≥90 mm Hg or self-reported use of antihypertensive medication. Detection was defined as self-reported prior diagnosis by a health professional or reported use of antihypertensive medication. Controlled hypertension was defined as SBP <140 mm Hg and DBP <90 mm Hg among those receiving antihypertensive treatment.
Overall, 37.2% of participants had hypertension, with higher age-standardised prevalence in men than women (41.9% vs 28.6%). Prevalence increased markedly with age, from 23% to 73% in men and from 10% to 69% in women at ages 18-39 and ≥80 years, respectively. Despite this high burden, 58.8% of individuals with hypertension were undetected. Hypertension was strongly associated with older age, male sex and higher body mass index, but the prevalence remained substantial across all population subgroups. Factors associated with hypertension detection largely mirrored those associated with hypertension, except in individuals with prior cardiovascular disease or diabetes, among whom detection was higher. Among detected participants, antihypertensive treatment was associated with lower odds of uncontrolled blood pressure; however, 50.2% of treated individuals did not achieve blood pressure control.
Over one-third of adults in England had hypertension, yet only half of affected individuals were detected and half of those treated achieved blood pressure control. The high prevalence across nearly all population subgroups underscores the need for population-wide prevention strategies alongside targeted treatment of individuals at high cardiovascular risk.
PMID:
42825274
Bibliographic data and abstract were imported from PubMed on 02 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 1
- Comments 0